17 research outputs found
Susceptibility profile of yeast-like organisms isolated from HIV/AIDS patients; using NCCLs macrodiltion method compared with agar diffusion technique.
Yeast like opportunistic fungal infection has been reported globally amongst HIV/AIDS patients, particularly as the etiologic agent of oral thrush. Fluconazole antibiotic has been most popularly employed in treating cases of oral thrush in HIV/AIDS patients. Recent reports have recorded antifungal drug resistance amongst immunocompromised subjects. This constitutes a big problem in the management of opportunistic candidiasis. The NCCLS micro/macrodilusion sensitivity testing procedure is expensive, cumbersome and requires a level of sophistication. This study was designed to compare NCCLS M-27-A macrodilution method (expensive) with agar diffusion technique (cheap and simple), to provide a reliable rapid alternative to the new pressing need for antifungal routine sensitivity testing. Sputum specimens from 213(108 females and 105 males) HIV positive patients were plated onto SDA. The isolates were identified by morphotyping, microscopy and speciated using germ tube test, and battery of biochemical sugar fermentation; and assimilation tests. Fluconazole agar diffusion susceptibility testing was carried out on each isolate, compared with the NCCLS macrodilution sensitivity assay standard.
Of the 74 isolates tested for fluconazole sensitivity, 59(79.7%) were sensitive (zone diameter > 19mm, mean diameter 28mm), 6(8.1%) were Sensitive Dose Dependent (S-DD) (zone diameter 13-18mm, mean diameter 16mm), while 9(12.2%) were resistant (zone diameter 64μg/ml profile, using the NCCLS macrodilution assay. The differences between the test method (Agar diffusion) and the control standard method (NCCLS-M 27-A broth Macrodilution MICS) were not statistically significant using t-test (two tail) (t = 4.302656, P=1.0). Among the C. albicans isolates, 26(86.7%) were sensitive to fluconazole. The rank of susceptibility was C. albicans > C. tropicalis > C. krusei.
It is concluded that broncho-oro-pharyngeal Candida and other yeast-like species existed in about one third of the HIV and AIDS patients studied; in which C. albicans was the most prevalent, while about ten percent of all the Candida isolates were resistant to fluconazole. The reliability of germ tube production as a confirmatory test for Candida albicans in HIV infection was as high as 96.7% and is therefore, recommended for continued use. Agar diffusion compared favourably with the NCCLS macrodilution technique, hence it is recommended for routine antifungal sensitivity test on all isolates of yeast-like cells from HIV and AIDS subjects.
Keywords: HIV/AIDS, oral thrush, yeast-like cells, fluconazole resistance, NCCLS vs agar diffusion technique.African Journal of Clinical and Experimental Microbiology Vol. 9 (2) 2008 pp. 88-9
Bronchopulmonary Tuberculosis- Laboratory Diagnosis And Dots Strategy Outcome In A Rural Community: A Retrospective Study
Pulmonary tuberculosis is still a global public health threat. Despite all efforts at its containment, the scourge is still menacing especially in the rural communities and among HIV infected patients. This retrospective study was carried out to determine the case detection rate of pulmonary tuberculosis in a rural community hospital in Nigeria from 2001-2006. A total of 1219 suspected patients were tested for pulmonary tuberculosis by sputum smear stained by Ziehl-Neelsen technique. Out of this number, 350 (28.7%) were positive for Acid-Fast Bacilli including 198 males and 152 females. Also 235 of the sputum-smear positive patients were tested for the human immunodeficiency virus (HIV) antibodies by Immunocomb 11 HIV 1 & 2 Bispot and confirmed by Immunocomb 11 HIV 1 & 2 Combfirm and HIV-1 Western Blot kit. Sixty three (26.8%) of the sputum-smear positive patients were co-infected with HIV. Two hundred and seventy (77.1%) of the AFB positive patients were treated under the Directly Observed Therapy-Short course, 201 of them (74.4%) completed the treatment, 39 (14.4%) defaulted, 30 (11.1%) died before the completion of the treatment, 195 of the patients were declared cured and 6 were declared failed. Case detection rates could be improved upon by providing culture facilities at the DOTS centers. Also efforts should be made to ensure that all positive cases are followed to a logical conclusion and that anti-retroviral drugs are provided for patients co-infected with HIV to reduce the mortality rate of pulmonary tuberculosis
Patient and provider delay in tuberculosis suspects from communities with a high HIV prevalence in South Africa: A cross-sectional study
BACKGROUND: Delay in the diagnosis of tuberculosis (TB) results in excess morbidity and mortality, particularly among HIV-infected individuals. This study was conducted at a secondary level hospital serving communities with a high HIV prevalence in Cape Town, South Africa. The aim was to describe patient and provider delay in the diagnosis of TB in patients with suspected TB requiring admission, and to determine the risk factors for this delay and the consequences. METHODS: A cross-sectional study was conducted. Patients admitted who were TB suspects were interviewed using a structured questionnaire to assess history of their symptoms and health seeking behaviour. Data regarding TB diagnosis and outcome were obtained from the medical records. Bivariate associations were described using student's T-tests (for means), chi-square tests (for proportions), and Wilcoxon rank-sum tests (for medians). Linear regression models were used for multivariate analysis. RESULTS: One hundred twenty-five (125) patients were interviewed. In 104 TB was diagnosed and these were included in the analysis. Seventy of 83 (84%) tested were HIV-infected. Provider delay (median = 30 days, interquartile range (IQR) = 10.3-60) was double that of patient delay (median = 14 days, IQR = 7-30). Patients had a median of 3 contacts with formal health care services before referral. Factors independently associated with longer patient delay were male gender, cough and first health care visit being to public sector clinic (compared with private general practitioner). Patient delay [greater than or equal to] 14 days was associated with increased need for transfer to a TB hospital. Provider delay [greater than or equal to] 30 days was associated with increased mortality. CONCLUSION: Delay in TB diagnosis was more attributable to provider than patient delay, and provider delay was associated with increased mortality. Interventions to expedite TB diagnosis in primary care need to be developed and evaluated in this setting
The road to tuberculosis treatment in rural Nepal: A qualitative assessment of 26 journeys
BACKGROUND: The fact that tuberculosis can be treated with the DOTS strategy (Directly Observed Treatment, Short-course) is not enough to control the disease. Patients have to find their way to tuberculosis treatment first. To better understand the route to tuberculosis treatment in rural Nepal we interviewed twenty-six patients under treatment. METHODS: In semi-structured interviews patients shared their disease history and health seeking behaviour. The analysis focused on the encounters with the health care system before enrolment in the tuberculosis treatment program. RESULTS: Patient routes often started in the medical shop and led via intricate routes with multiple providers to facilities with higher qualified and more competent staff where tuberculosis was diagnosed. Several factors influenced the route to tuberculosis treatment. Besides known patients factors (such as severity of complaints, the ability to pay for services, availability of services and peer support for choosing a provider) specific health services factors were also identified. These included the perceived quality, costs and service level of a provider, and lack of provider initiated referral. Self referral because of waned trust in the provider was very common. In contrast, once tuberculosis was considered a possible diagnosis, referral to diagnostic testing and tuberculosis treatment was prompt. CONCLUSION: Patient routes towards tuberculosis treatment are characterised by self referral and include both private and public health care providers. Once tuberculosis is suspected referral for diagnosis and treatment is prompt. Given the importance of the private practitioners in the patient routes, quality improvement initiatives need to address not only the public sector but the private health care sector as well
The Malawi National Tuberculosis Programme: an equity analysis
<p>Abstract</p> <p>Background</p> <p>Until 2005, the Malawi National Tuberculosis Control Programme had been implemented as a vertical programme. Working within the Sector Wide Approach (SWAp) provides a new environment and new opportunities for monitoring the equity performance of the programme. This paper synthesizes what is known on equity and TB in Malawi and highlights areas for further action and advocacy.</p> <p>Methods</p> <p>A synthesis of a wide range of published and unpublished reports and studies using a variety of methodological approaches was undertaken and complemented by additional analysis of routine data on access to TB services. The analysis and recommendations were developed, through consultation with key stakeholders in Malawi and a review of the international literature.</p> <p>Results</p> <p>The lack of a prevalence survey severely limits the epidemiological knowledge base on TB and vulnerability. TB cases have increased rapidly from 5,334 in 1985 to 28,000 in 2006. This increase has been attributed to HIV/AIDS; 77% of TB patients are HIV positive. The age/gender breakdown of TB notification cases mirrors the HIV epidemic with higher rates amongst younger women and older men. The WHO estimates that only 48% of TB cases are detected in Malawi. The complexity of TB diagnosis requires repeated visits, long queues, and delays in sending results. This reduces poor women and men's ability to access and adhere to services. The costs of seeking TB care are high for poor women and men – up to 240% of monthly income as compared to 126% of monthly income for the non-poor. The TB Control Programme has attempted to increase access to TB services for vulnerable groups through community outreach activities, decentralising DOT and linking with HIV services.</p> <p>Conclusion</p> <p>The Programme of Work which is being delivered through the SWAp is a good opportunity to enhance equity and pro-poor health services. The major challenge is to increase case detection, especially amongst the poor, where we assume most 'missing cases' are to be found. In addition, the Programme needs a prevalence survey which will enable thorough equity monitoring and the development of responsive interventions to promote service access amongst 'missing' women, men, boys and girls.</p
Patient and health system delay among patients with pulmonary tuberculosis in Beira city, Mozambique
Phytochemical evaluation and antibacterial profile of Treculia africana Decne bark extract on gastrointestinal bacterial pathogens
Treculia africana Decne (Fam. Moraceae) is a highly valued economic plant, as well as an important medicinal plant widely used in the traditional herbal medicine for the treatment of several ailments ofboth microbial and non-microbial origins. It was, therefore, investigated for activity in vitro on pathogenic bacterial isolates of gastrointestinal tract. Fresh plant materials were collected from the Forestry Division in Oyo State and the aqueous ethanol (70%) extracts of the powdered bark were obtained by maceration method. The bacterial organisms tested were Salmonella typhi (ATCC24682), Shigella dysentriae (ATCC23513), Escherichia coli (Clinical isolate), Pseudomonas aeruginosa (ATCC12462) and Staphylococcus aureus (ATCC23815). Susceptibility testing and phytochemical screening of the plant extracts were performed by standard procedures. Aqueous ethanol extract of T.africana was effective on the tested organisms. The mean Minimum Inhibition Concentration (MIC) of the extract ranged from 3.125 to 25 mg/ml for different organisms tested. The extract exhibitedminimum bactericidal concentration (MBC) of 50 mg/ml on S. dysentriae and P. aeruginosa only, while other tested bacteria strains required higher concentrations. Phytochemical screening revealed thepresence of steroidal saponin glycosides as the major component, anthraquinone glycoside and polyphenols. Our results offer a scientific basis for the traditional use of T. africana. The aqueousethanol extract of the bark was effective in vitro in this study on gastrointestinal bacteria pathogens, and thus could be explored for further pharmaceutical use
Evaluation of antibacterial activity and acute toxicity of the hydroethanolic extract of Stachytarpheta angustifolia (Mill) Vahl.
The aim of this study was to evaluate antibacterial activity, acute toxicity in mice and phytochemical profiles of hydroethanolic extract of Stachytarpheta angustifolia plant. The plant S. angustifolia hasattracted the attention of the researchers because of its use as an anti-infection agent. The aqueous ethanol (80%) extract of the powdered dried whole plant was obtained by maceration. The bacteriaorganisms tested include Shigella dysentriae (ATCC 32412), Salmonella typhi (ATCC 213415), and the following clinical isolates: coagulase-negative Staphylococcus, Staphylococcus aureus, Proteusmirabilis, Klebsiella species and Escherichia coli. Susceptibility test, acute toxicity test and phytochemical screening of the plant extract were performed using standard procedures. The results showed that the extract had a good antibacterial activity against S. aureus, S. dysentriae, coagulasenegative Staphylococcus and Proteus mirabilis. The minimum inhibitory concentration (MIC) was foundto be between 11.6 and 14.0 mg/ml for the susceptible organisms. The extract exhibited minimum bactericidal concentration (MBC) of 150 mg/ml against S. dysentriae only while other susceptible testedbacteria strains required higher concentrations. The median acute toxicity value (LD50) of the extract was determined to be 8.721 g/kg body weight indicating the extract as being slightly toxic. The extractcontained triterpenoid saponins as the major bioactive constituent
Fluconazole resistant opportunistic oro-pharyngeal candida and non-candida yeast-like isolates from HIV infected patients attending ARV clinics in Lagos, Nigeria
Background: Oro-Pharyngeal Candidiasis (OPC) continues to be
considered the most common opportunistic fungal disease in HIV/AIDS
patients globally. Azole antifungal agent has become important in the
treatment of mucosal candidiasis in HIV patients. Presently, antifungal
drug resistance is fast becoming a major problem particularly with the
immune depleted population. Objectives: This study was designed to
investigate the: existence of OPC, species distribution fluconazole
susceptibility profile of yeast cells isolated from oral specimens of
HIV/AIDS patients from Lagos Nigeria, between Oct. 2004 and June, 2005.
Methodology: The venous blood samples were screened for HIV
antibodies using the Cappillus HIV I and II test kit (Trinity Biotech
Plc UK), and Genie II HIV I and II EIA kit (Bio-Rad France). The
positive results were subsequently confirmed at the laboratory attached
to each of the clinics, using the Nigerian Federal Ministry of Health
approved algorithm. The samples from 213 (108 females and 105 males)
HIV positive patients were plated onto SD agar. The isolates were
identified by morphotyping, microscopy and speciated using germ tube
test and battery of biochemical sugar fermentation and assimilation
tests. Fluconazole agar diffusion susceptibility testing was carried
out on each isolates. Results: Seventy-four (34.7%) isolates were
recovered including one person with double isolates. Only 70(94.6%) of
the isolates could be adequately speciated. Candida albicans 30
(40.5%) was the most frequently isolated species, the rest were
non-albicans species, with the frequency of C. tropicalis > C.
Krusei > C. glabrata and C. neoformans for species for species
having up to 4 isolates. Four (30.8%) out of 13 isolates of C.
tropicalis showed germ tube formation. While one C. albicans was
germ-tube negative. Out of the 74 isolates tested for fluconazole
sensitivity, 58(78.4%) were sensitive, MIC d" 8µg/ml, 9(12.1%)
were susceptible Dose Dependant (S-DD), MIC 16-32 µg/ml and
7(9.5%) were resistant, MICs e" 64µg/ml. Among the C. albicans
isolates, 26(86.7%) were sensitive to fluconazole. The rank of
susceptibility was C. albicans > C. tropicalis > C. Krusei for
the most prevalent species. Conclusion: We conclude that fluconazole
resistant strains of oro-pharyngeal yeast-like cells exist in about
9.5% of HIV/AIDS patients with the above stated species distribution.
We therefore, highlight the need for routine antifungal susceptibility
testing on HIV patients with cases of initial or repeat episodes of
OPC
Fluconazole resistant opportunistic oro-pharyngeal candida and non-candida yeast-like isolates from HIV infected patients attending ARV clinics in Lagos, Nigeria.
Background: Oro-Pharyngeal Candidiasis (OPC) continues to be considered the most common opportunistic fungal disease in HIV/AIDS patients globally. Azole antifungal agent has become important in the treatment of mucosal candidiasis in HIV patients.
Presently, antifungal drug resistance is fast becoming a major problem particularly with the immune depleted population.
Objectives: This study was designed to investigate the: existence of OPC, species distribution fluconazole susceptibility profile of yeast cells isolated from oral specimens of HIV/AIDS patients from Lagos Nigeria, between Oct. 2004 and June, 2005.
Methodology: The venous blood samples were screened for HIV antibodies using the Cappillus HIV I and II test kit (Trinity Biotech Plc UK), and Genie II HIV I and II EIA kit (Bio-Rad France). The positive results were subsequently confirmed at the laboratory
attached to each of the clinics, using the Nigerian Federal Ministry of Health approved algorithm. The samples from 213 (108 females and 105 males) HIV positive patients were plated onto SD agar. The isolates were identified by morphotyping, microscopy and
speciated using germ tube test and battery of biochemical sugar fermentation and assimilation tests. Fluconazole agar diffusion susceptibility testing was carried out on each isolates.
Results: Seventy-four (34.7%) isolates were recovered including one person with double isolates. Only 70(94.6%) of the isolates could be adequately speciated. Candida albicans 30 (40.5%) was the most frequently isolated species, the rest were non-albicans
species, with the frequency of C. tropicalis › C. Krusei › C. glabrata and C. neoformans for species for species having up to 4 isolates. Four (30.8%) out of 13 isolates of C. tropicalis showed germ tube formation. While one C. albicans was germ-tube negative. Out of the 74
isolates tested for fluconazole sensitivity, 58(78.4%) were sensitive, MIC d” 8μg/ml, 9(12.1%) were susceptible Dose Dependant (SDD), MIC 16-32 μg/ml and 7(9.5%) were resistant, MICs e” 64μg/ml. Among the C. albicans isolates, 26(86.7%) were sensitive to
fluconazole. The rank of susceptibility was C. albicans > C. tropicalis > C. Krusei for the most prevalent species.
Conclusion: We conclude that fluconazole resistant strains of oro-pharyngeal yeast-like cells exist in about 9.5% of HIV/AIDS patients with the above stated species distribution. We therefore, highlight the need for routine antifungal susceptibility testing on HIV patients with cases of initial or repeat episodes of OPC. Keywords: Oropharyngeal Candida (yeast-like cells), HIV/AIDS and Fluconazole Resistance. African Health Sciences Vol. 8 (3) 2008: pp. 142-14